Article
Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.
Clinical pharmacology and therapeutics - 1 Apr 2005
Rodríguez-Antona Cristina, Jande Mary, Rane Anders, Ingelman-Sundberg Magnus
Abstract excerpt
BACKGROUND: The fetal liver cytochrome P450 (CYP) 3A enzymes metabolize potentially toxic and teratogenic substrates and drugs in addition to endogenous hormones and differentiation factors. CYP3A7 is the most abundant CYP in the human liver during fetal stages and the first months of postnatal age and shows a large interindividual variability of unknown molecular basis. METHODS: A new variant gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
